PVI
BBNX

Pura Vida Investments’s Beta Bionics BBNX Stock Holding History

Pura Vida Investments’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.82M Hold
281,250
– – 18.94% 2
2025
Q4 		$8.57M Hold
281,250
– – 32.03% 1
2025
Q3 		$5.59M Buy
281,250
+278,750
+11,150% +$4.9M 34.05% 1
2025
Q2 		$6.25M Sell
2,500
-426,620
-99% -$6.04M 37.57% 1
2025
Q1 		$5.25M Buy
+429,120
New +$8M 38.36% 1

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Pura Vida Investments's BBNX Position: Q1 2026 in Review

Pura Vida Investments held its Beta Bionics (BBNX) position steady in Q1 2026 at 281,250 shares worth $2.82M. The position accounts for 18.94% of the portfolio, ranked #2.

Pura Vida Investments first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $8.57M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Pura Vida Investments held 281,250 shares of Beta Bionics worth $2.82M as of Q1 2026.
  • Pura Vida Investments left its Beta Bionics share count unchanged in Q1 2026.
  • Beta Bionics made up 18.94% of Pura Vida Investments's portfolio in Q1 2026, its #2 holding.
  • Pura Vida Investments first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Pura Vida Investments's Beta Bionics position peaked at $8.57M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Pura Vida Investments's 13F filing for Q1 2026, filed 12 May 2026.